SS-31
SS-31, also known as Bendavia or elamipretide, is a mitochondria-targeting peptide that accumulates in mitochondria and scavenges reactive oxygen species. It is a small, cell-permeable molecule that selectively targets the inner mitochondrial membrane, where it interacts with cardiolipin, a key phospholipid component.
This interaction helps stabilize mitochondrial membranes, optimize the function of the electron transport chain and alleviate oxidative stress.
1. Mitochondrial protection: SS-31 enhances the structural integrity and function of mitochondria, protecting them from damage caused by oxidative stress, a major contributor to various diseases and aging processes.
2. Energy production: By preserving mitochondrial function, SS-31 promotes efficient ATP production through the electron transport chain, supporting cellular energy metabolism.
3. Anti-inflammatory effects: SS-31 has been shown to reduce inflammation by inhibiting the release of pro-inflammatory cytokines and suppressing the activation of inflammatory pathways in cells.
4. Cardioprotection: Studies have demonstrated the cardioprotective effects of SS-31, including its ability to improve cardiac function, reduce ischemia/reperfusion injury and improve recovery from myocardial infarctions.
5 Neuroprotection: SS-31 has shown promise in protecting neurons from oxidative damage and improving mitochondrial function in neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
POSSIBLE APPLICATIONS OF SS-31
1. Treatment of mitochondrial disorders: SS-31 has potential as a therapeutic agent for various mitochondrial disorders, including mitochondrial myopathy, Leigh syndrome and mitochondrial encephalopathy.
2. Cardiac diseases: given its cardioprotective effect, SS-31 can be used to prevent or treat heart failure, myocardial infarction and other cardiovascular conditions.
3. Neurological disorders: SS-31 may have applications in the treatment of neurodegenerative diseases characterized by mitochondrial dysfunction, such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
4. Anti-aging interventions: Since mitochondrial dysfunction is a hallmark of aging, SS-31 could potentially be used as an anti-aging peptide to maintain mitochondrial health and delay age-related decline.
5. Improving athletic performance: By improving cellular energy production and reducing oxidative stress, SS-31 may have applications in improving athletic performance and aiding post-training recovery.
6. Reducing oxidative stress: Oxidative stress is a hallmark of aging and is associated with the development of many age-related diseases, including cardiovascular disease, neurodegenerative disorders and metabolic syndrome. The antioxidant properties of SS-31 enable it to scavenge reactive oxygen species (ROS) and reduce oxidative damage, thereby potentially alleviating age-related oxidative stress and associated pathologies.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103197/
https://pubmed.ncbi.nlm.nih.gov/23813215/
https://stealthbt.com/wp-content/uploads/Stauffer-ESC-HF-Abstract_1238_MTP131-and-cardiolipin.pdf
